Background: Climate change poses significant risks to both the environment and public health. The Canadian health care system accounts for an estimated 4.6% of national carbon emissions, and hospital pharmacy contributes substantially to these emissions.
Objectives: To evaluate the awareness of green initiatives and green practices in hospital pharmacy and to explore the overall interest of pharmacy staff in improving on sustainable and climate-resilient pharmacy practices.
Methods: A cross-sectional survey was administered securely online to Canadian hospital pharmacy staff, between February 15 and April 30, 2023. The survey contained 38 questions with specified themes related to sustainability and climate resilience.
Results: A total of 214 participants responded to the survey. Of these, 84% (141/167) were motivated or highly motivated to engage in sustainable pharmacy practices. When asked about specific green initiatives planned by their hospital, 53% (109/206) reported not being aware of any initiatives, and 10% (20/206) indicated that no plans existed. The green practices that were at least partially implemented were "reduced paper use" (27% of responses), "improved recycling programs" (18%), and "raised awareness" (11%). The top 3 areas of pharmacy waste were identified as "single-use plastic" (28% of responses), "excessive paper use" (18%), and "improper recycling" (17%). The top 3 barriers to implementing eco-friendly practices were identified as "cost" (50% [83/166]), "time consumption" (50% [83/166]), and "added complexity" (30% [49/166]).
Conclusions: Hospital pharmacy staff participating in this survey study shared a willingness and strong motivation to engage in more sustainable and climate-resilient pharmacy practices, but they reported significant barriers, such as time consumption and perceived complexity, that must be addressed in implementing these changes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11879366 | PMC |
| http://dx.doi.org/10.4212/cjhp.3608 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A mixed-methods study assessing the performance of a clinical decision support tool for testing for patients receiving laxatives.
Infect Control Hosp Epidemiol
March 2025
Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Objective: To better understand clinicians' rationale for ordering testing for infection (CDI) for patients receiving laxatives and the impact of the implementation of a clinical decision support (CDS) intervention.
Design: A mixed-methods, case series was performed from March 2, 2017 to December 31, 2018.
Setting: Yale New Haven Hospital, a 1,541 bed tertiary academic medical center.
Identification and validation of transcriptome-wide association study-derived genes as potential druggable targets for osteoarthritis.
Bone Joint Res
March 2025
Department of Orthopedics, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China.
Aims: Osteoarthritis (OA) is a widespread chronic degenerative joint disease with an increasing global impact. The pathogenesis of OA involves complex interactions between genetic and environmental factors. Despite this, the specific genetic mechanisms underlying OA remain only partially understood, hindering the development of targeted therapeutic strategies.
View Article and Find Full Text PDFIntegration of Photodiagnosis and Therapy Guided by Micro/Nanorobots.
Adv Mater
March 2025
Engineering Research Center for Pharmaceuticals and Equipments of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, 610106, China.
Micro/Nanorobots(MNRs)integrated with phototherapy represent an emerging approach to cancer treatment and hold significant potential for addressing bacterial infections, neurological disorders, cardiovascular diseases, and related conditions. By leveraging micro/nanoscale motor systems in conjunction with phototherapy, these robots enable real-time guidance and monitoring of therapeutic processes, improving drug delivery precision and efficiency. This integration not only enhances the effectiveness of phototherapy but also minimizes damage to surrounding healthy tissues.
View Article and Find Full Text PDFOpioid withdrawal syndrome induced by naldemedine administration in a cancer patient without brain metastasis.
Palliat Support Care
March 2025
Departments of Psycho-oncology, Saitama Medical University International Medical Center, Saitama, Japan.
Objectives: Naldemedine is a peripherally acting μ-opioid receptor antagonist used to treat opioid-induced constipation. As this drug does not cross the blood-brain barrier, it is believed that patients without brain metastases do not experience opioid withdrawal symptoms.
Methods: Here, we experienced a case in which a cancer patient without brain metastasis presented with anxiety and restlessness that was severe enough to interfere with daily life.
Left-sided appendicitis revealing situs inversus: diagnostic challenges and emergency surgical management strategies - a case report.
J Surg Case Rep
March 2025
Department of Visceral Surgery and Digestive Oncology A, Mohammed VI University Hospital, BP 4806 Oujda Universite, 60049 Oujda, Morocco.
Situs inversus is a rare congenital anomaly that results in the transposition of the abdominal organs, leading to atypical clinical presentations, such as left-sided appendicitis. Acute appendicitis is the most common cause of right iliac fossa pain; however, its occurrence on the left side is exceedingly rare and often leads to diagnostic delays, which may result in serious complications such as peritonitis if not promptly addressed. Imaging modalities, particularly computed tomography (CT), play a critical role in the anatomical and pathological diagnosis, thereby guiding appropriate surgical management.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!